Image Description (Logo1)
Sildenafil Citrate Tablet, Film Coated
Product Images NDC 67296-2241
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 67296-2241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical-structure (Chemical Structure)
Figure-1 (Figure 1)
This is a record of systolic blood pressure readings taken before and after the administration of a medication. The medication mentioned is likely Sildenafil 100mg, potentially compared with a placebo. The readings appear to be in millimeters of mercury (mmHg).*
Figure-2 (Figure 2)
Figure-3 (Figure 3)
This text provides data related to the change in Systolic Blood Pressure (SBP) in millimeters of Mercury (mmHg) over time (in hours) for different treatments involving Doxazosin, Placebo, and Sildenafil 50 mg. The numerical values in the text indicate the change in SBP at specific time points post-dose administration.*
Figure-4 (Figure 4)
This text provides information about the combination of Doxazosin with Sildenafil and Doxazosin with Placebo at different time points after dosing, as indicated by the hours on the graph axis. The unit of measurement presented is mmHg.*
Figure-5 (Figure 5)
This text provides data on plasma concentrations in ng/ml over time post-dose (in hours) for a commercial tablet labeled as "©-6-6". The concentrations are given at different time points ranging from 0 to 24 hours post-dose. This information may be useful for pharmacokinetic studies or medication monitoring.*
Figure-6-1 (Figure 6 1)
This text provides data on the percentage of patients at the endpoint with varying scores. It includes values such as 80%, 70%, 60%, 5%, 8%, and so on. The information seems to be related to patient assessment or outcomes.*
Figure-6-2 (Figure 6 2)
Figure-7 (Figure 7)
This is a report on the percentage of patients reporting improvement after taking different dosages of sildenafil citrate and a placebo. The data includes the percentages for each group: 100mg - 82%, 50mg - 74%, 25mg - 63%, and placebo - 24%. The study involved 463 participants for the placebo, and 214, 391, and 380 participants for the 25mg, 50mg, and 100mg dosage groups respectively.*
Label-100mg-30s-indrad (Sildenafiltablet 100mg 30tablets Indrad)
The text provided contains information about film-coated tablets containing sildenafil citrate USP, each tablet equivalent to 100 mg of sildenafil. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). The tablets should be dispensed in a tight container with a child-resistant closure. The usual dosage instructions can be found in the accompanying prescribing information. Patent information is available at the provided website. The tablets are manufactured by Torrent Pharmaceuticals LTD in Indrad, India.*
Label-100mg-30s-dahej (Sildenafiltablets 100mg 30tablets Dahej)
This is a medication containing sildenaiilcitrate USP, equivalent to 100 mg of sigenafil. The usual dosage and additional information can be found on the prescribing information available at the provided website. It is advisable to store the tablets at a temperature between 20°C to 25°C, with excursions permitted between 15°C and 30°C. The tablets are film-coated and come in a pack of 30 tablets. The medication is manufactured by Torrent Pharmaceuticals LTD.*
Label-25mg-30s-dahej (Sildenafiltablets 25mg 30tablets Dahej)
Each film-coated tablet of this product contains sildenafil citrate USP, equivalent to 25 mg of sildenafil. It should be stored at a temperature ranging from 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). The tablets should be dispensed in a tight container with a child-resistant closure. The prescribed dosage information can be found in the accompanying prescribing information. Patient information is available online at the specified website. This product is manufactured by Torrent Pharmaceuticals LTD. in India. The package contains 30 tablets, with the NDC 13668-186-30.*
Label-25mg-30s-indrad (Sildenafiltablets 25mg 30tablets Indrad)
This text appears to be a description of a medication containing sildenafil citrate USP in film-coated tablets, with each tablet equivalent to 25 mg of sildenafil. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). The tablets should be dispensed in a tight container with a child-resistant closure. The manufacturer is Torrent Pharmaceuticals LTD. Additional prescribing and patient information can be found at their website: https://torrentpharma.com/pi/usa/products/.*
Label-50mg-30s-dahej (Sildenafiltablets 50mg 30tablets Dahej)
The text provides information about Sildenafil tablets, USP, containing 50mg of Sildenafil citrate. It includes guidelines for storage, dispensing, and additional patient information. The tablets are film-coated and are recommended to be stored between 20°C to 25°C. The product is produced by Torrent Pharma INC. and the dosage information is available in the accompanying prescribing information.*
Label-50mg-30s-indrad (Sildenafiltablets 50mg 30tablets Indrad)
This is information about film-coated tablets containing sildenafil citrate USP, equivalent to 50 mg of sildenafil. The tablets should be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Dispense in a tight container with a child-resistant closure. The usual dosage information can be found in the accompanying prescribing information. The tablets are manufactured by Lo GRn B and are available by prescription only. Additional patient information is available online at hitosy/horrentpharma com/oi/usa/products/.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
